Welcome to our dedicated page for Gyrodyne news (Ticker: GYRO), a resource for investors and traders seeking the latest updates and insights on Gyrodyne stock.
Gyrodyne, LLC (NASDAQ: GYRO) is an owner and manager of real estate properties in the New York metropolitan area, with assets that include a 63-acre mixed-use site at Flowerfield on Long Island and a medical office park in Cortlandt Manor, New York. The company’s news flow reflects its focus on property entitlements, asset sales, capital raising and governance developments.
On this page, readers can follow transaction-related announcements such as Gyrodyne’s purchase and sale agreement for approximately 49 acres of vacant land within the Flowerfield complex in St. James, New York. Company releases describe how such agreements relate to its strategic plan and estimated net asset value in liquidation.
Gyrodyne also issues legal and regulatory updates, including decisions affecting zoning and subdivision approvals. For example, the company has reported on a New York Supreme Court ruling that dismissed a petition challenging the Town of Smithtown Planning Board’s approval of an eight-lot subdivision of the Flowerfield property, which Gyrodyne characterized as a major milestone for its plans.
Investors can review capital markets news such as the commencement and closing of a rights offering registered on Form S-1, in which existing shareholders were granted subscription rights to purchase additional common shares. Gyrodyne has explained how proceeds from the rights offering are intended to support entitlements, litigation expenses, property transactions, capital improvements and working capital during its liquidation process.
In addition, Gyrodyne’s news includes corporate governance and shareholder engagement items, including agreements with activist funds like Star Equity Fund, LP and Leap Tide Capital Management LLC, changes to board composition, director compensation arrangements and standstill provisions. For ongoing context on GYRO’s real estate strategy, property-level milestones and shareholder-related developments, this news feed aggregates the company’s public announcements over time.
Gyrodyne, LLC (Nasdaq: GYRO) issued a letter to shareholders from CEO Gary Fitlin on January 30, 2023, highlighting the company's continued focus on real estate with medical tenants, which has resulted in $147 million returned to shareholders. The company aims to maximize property values and distribute net asset values before dissolving by the end of 2024. Gyrodyne is addressing corporate governance concerns following the 2022 Annual Meeting and has made significant progress with its properties, including the Flowerfield and Cortlandt Manor sites. The company maintains a strong balance sheet, with debt at $9.8 million and a loan-to-value ratio of 23%.
Gyrodyne, LLC (NASDAQ: GYRO) announced that the Town of Smithtown Planning Board granted preliminary subdivision approval for its Flowerfield property on March 30, 2022. The approval is contingent on finalizing a stormwater pollution prevention plan and other requirements. This milestone follows extensive public comment and analysis under the State Environmental Quality Review Act (SEQRA). Gyrodyne is set to advance to final subdivision approval, needing further reviews from local and state authorities. The company will actively market the subdivided lots while seeking attractive offers for the property.